Publication August 1, 2026

GHK: New Publication in Mucosal Immunology on Influenza Vaccine Response

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

A new publication referencing GHK appeared in the journal Mucosal Immunology on August 1, 2026. The publication is titled "Mucosal immunity as a vaccine-induced correlate of protection against influenza."

This entry is listed under PubMed ID 42419427. The publication is noted here as a new addition to the literature, not as a summary of results.

No findings, conclusions, or data points from the study are detailed in the available record. Readers interested in the specifics of the study should consult the original publication directly through the provided source link.

GHK remains classified as an approved compound. This publication listing does not indicate any change to that regulatory status.

For general background on GHK, readers can consult the compound overview.

See the full ghk overview

Source: https://pubmed.ncbi.nlm.nih.gov/42419427/